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Identification of a Naturally Occurring Ligand
for Thymic Positive Selection
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et al. showed that low concentrations of the antigenicWilliam C. Kieper,* Maureen A. McGargill,*
peptide drove positive selection while high concentra-Marilyn C. Hart,³ Stephen Naylor,²
tions drove negative selection. In contrast, in OT-I mice,and Stephen C. Jameson*
which express a TCR specific for ovalbumin257±264 (OVAp)*Department of Laboratory Medicine and Pathology
with Kb, the antigenic peptide itself exclusively causedand the Center for Immunology
negative selection of thymocytes (Hogquist et al., 1994,University of Minnesota
1995). However, variants of OVAp induced positive se-Minneapolis, Minnesota 55455
lection. In this system, the most potent positive selecting²Biomedical Mass Spectrometry Facility
ligands also had the property of being potent TCR antag-and Department of Biochemistry and Molecular Biology
onists for mature T cells. Recent data showed that theMayo Clinic
TCR affinity for Kb bound to these positive selectingRochester, Minnesota 55905
peptide variants is lower than that for OVAp/Kb (Alam et³Department of Cell Biology
al., 1996), but only by a small factor. Thus, while it seemsWashington University
clear that TCR avidity and affinity influencethymic selec-St. Louis, Missouri 63110
tion, other factors, such as a potential conformational
change, may also be involved (Janeway, 1995; Margu-Summary
lies, 1996).
A major limitation in these studies is that the positiveIn the thymus, positive and negative selection shape
selecting peptide ligands were derived from knowledgethe T cell repertoire. It has previously been shown that
of the antigenic peptide. Although these synthetic pep-positive selection, like negative selection, is the result
tide ligands can induce development of cells that areof the interaction of the TCR with self-peptides bound
phenotypically and functionally indistinguishable fromto MHC. However, little is known about the number or
those selected by ªnaturalº positive selection, there isnature of the self-peptide ligands that mediate positive
no evidence that the self peptides that mediate positiveselection in vivo. We devised a novel assay with en-
selection in vivo have any relationship to the antigenichanced sensitivity for low affinity TCR ligands to iden-
peptide. Indeed, Pawlowski et al. (1996) showed thattify self-peptides that may be biologically relevant. At
highly divergent peptides were capable of selecting theleast eight Kb-bound self-peptides were detected by
2C TCR specific for Ld. Additionally, a recent reportthis assay using thymocytes bearing the OT-I TCR
identified putative self-peptides from the mouse data-(specific for OVAp/Kb). The sequence of one of these
base that had some homology toa hemoglobin antigenic
peptideswas determined usingthe recently developed peptide and a subset of these were able to stimulate T
technique of membrane preconcentration-capillary
cells specific for I-Ek/Hb (Evavold et al., 1995). Although
electrophoresis-tandem mass spectrometry. This pep- these are interesting candidates for ligands that regulate
tide, CPa1, has limited sequence similarity to OVAp, T cell development and reactivity, actual presentation
yet was found to induce positive selection of OT-I thy- of the peptides in vivo has not been demonstrated.
mocytes in fetal thymic organ culture. Two unresolved issues regarding the role of self-pep-
tides in positive selection in vivo, are, first, the nature
Introduction of the self-peptides that affect selection, specifically
their structural relationship to the antigenic peptide, and
Thymocytes must run the gauntlet of positive and nega- second, the number of self-peptides involved in select-
tive selection in order to mature (Kisielow and von ing an individual TCR. In addition, self-peptides may
Boehmer, 1995). The result of these selective events is regulate peripheral T cell function such as memory
chiefly dictated by the clonotypic T cell receptor (TCR). (Grossman and Paul, 1992). To begin to investigate
To survive positive selection, the TCR of a thymocyte these questions, we developed a novel assay that de-
must interact with self±major histocompatibility com- tects peptides capable of engaging thymocytes ex-
plex (MHC) molecules expressed on thymic epithelial pressing the OT-I TCR. Using this method to screen
cells (Fink and Bevan, 1978; Laufer et al., 1996). At the peptides immunoprecipitated with the relevant MHC
same time, however, the interaction of the receptor with molecule (Kb), we report the approximate number of self-
MHC molecules in the thymus must not be too ªstrongº peptides that can interact with a single TCR. Further-
or tolerance will dominate, eliminating the thymocyte more, we applied a sensitive mass spectrometry±based
through negative selection. Since both positive and neg- approach to sequence one of these self-peptides and
ative selection can be mediated by the same MHC al- showed that it can induce positive selection of thymo-
leles, the MHC-bound peptides are believed to play a cytes with the OT-I receptor.
critical role in shaping the TCR repertoire. To study
this process, we and others have used fetal thymic Results
organ culture (FTOC) to define the peptide requirement
for positive and negative selection of class I MHC± General Approach: The Modified
restricted CD8 T cells (Hogquist et al., 1994; Ashton- DP Dulling Assay
Rickardt et al., 1994; Sebzda et al., 1994, 1996; Pawlow- FTOC has been used to identify peptides that have the
ability to induce positive selection of TCR transgenicski et al., 1996). Using the P14 TCR transgenic, specific
Immunity
390
thymocytes (Hogquist et al., 1994; Ashton-Rickardt et APC that lack surface MHC class I molecules (Figure
1A, none and TAPo). In the presence of the antigenical., 1994; Sebzda et al., 1994; Pawlowski et al., 1996).
This assay has limited use in screening self-peptides peptide, the DP cells undergo a dramatic loss of surface
expression of CD4 and CD8 (Figure 1A, TAPo plus OVAp).extracted from tissues because of the large amounts of
peptide required. Hence we sought to develop an assay Of special interest here, when thymocytes were cocul-
tured with APC expressing Kb (without exogenous pep-requiring less peptide material that would detect self-
ligands for the TCR, with the idea that these might in- tide added), DP dulling was reproducibly observed (Fig-
ure 1A, B6). That this effect involves specific TCRclude peptides involved in thymic selection. We used a
modification of the ªDP dullingº assay, which is thought recognition, rather than a non-allele-specific interaction
of class I MHC with the overexpressed CD8, was demon-to mimic negative selection in vitro (Swat et al., 1991)
and is highly sensitive (Pircher et al., 1991; Vasquez et strated by the result that bm8 APC do not cause dulling
(Figure 1A, bm8). B6 and bm8 mice have similar levelsal., 1992; Barnden et al., 1994). In this assay, thymocytes
are cocultured with antigen-presenting cells (APC) for of cell surface class I MHC, and differ only by four amino
acids in their H-2K alleles. However, Kbm8 does not posi-18 hr. In the presence of antigenic peptide ligands and
the appropriate MHC, CD41CD81 double positive (DP) tively select OVA/Kb-specific TCRs (Nikolic Zugic and
Bevan, 1990), including the OT-I receptor (data notthymocytes exhibit a decreased surface expression of
their coreceptors, and in some situations die (Page et shown). Thus, activity in the dulling assay correlates
with ability to engage the TCR in vivo. Interestingly,al., 1993).
To enhance the sensitivity of the DP dulling assay, thymocytes from OT-I,b2Mo mice that do not overex-
press CD8 also undergo dulling when exposed to B6we used thymocytes from mice that overexpress the
class I MHC coreceptor, CD8. When CD8 transgenic APC (Figure 1B). This is consistent with the recent sug-
gestion that DP dulling is a consequence of positivemice were bred to the 2C TCR transgenic mice, negative
selection was seen on a background (H-2b), which nor- selection in vivo (Lucas and Germain, 1996 and refer-
ences therein).mally supported positive selection (Robey et al., 1992;
Lee et al., 1992), indicating that the coreceptor may be Although mice deficient in the transporters associated
with antigen processing (TAPo) do not load endogenousable to increase the normallyweak interaction between a
TCR and its positive selection ligand such that negative peptides into class I MHC molecules, exogenous pep-
tides bind very well (Van Kaer et al., 1992). Therefore,selection results. We therefore bred CD8ab transgenics
(Robey et al., 1991) with the OT-I strain. To prevent the dulling assay provides a convenient and sensitive
way to screen synthetic peptides or complex mixturesnegative selection from occurring in vivo and limiting
our ability to observe it in vitro, we backcrossed the of purified self-peptides. Figure 2 shows that this assay
detects synthetic peptide ligands that fail to stimulateanimals onto a nonselecting (b2M-deficient) background.
Thymocytes from CD8tg, OT-I,b2Mo animals consist mature T cells. The peptides E1 and V-OVA, when com-
plexed to Kb, bind the OT-I TCR with low affinity (Alamlargely of DPs and a small percentage of CD4 single
positive cells. This phenotype is not significantly altered et al., 1996). Both induce positive selection in FTOC but
are unable to stimulate a response by OT-I CTL, evenwhen the cells are cocultured overnight alone or with
Figure 1. The DP Dulling Assay Detects the Interaction of Thymo-
cytes with Self-MHC Molecules
(A) CD8tg, OT-I,b2Mo thymocytes were cultured either alone (no
APC), with APC from various strains of mice (TAPo, B6, and bm8),
or with TAPo cells in the presence of 10 nM OVAp peptide. The
expression of endogenous (non-transgene-encoded) CD8 (X axis)
and CD4 (Y axis) were detected by flow cytometry after gating on
live cells. The percentage of cells in the DP gate is indicated.
(B) Thymocytes from OT-I,b2Mo mice that were either CD8tg (solid
bars) or not (shaded bars) were compared for activity in the DP
dulling assay in response to wild-type C57BL/6 (B6) or TAPo APC.
10 nM OVAp was present in the TAPo cultures. The data are ex-
pressed as percent activity, where the percentage of DP remaining
in the TAPo (no peptide) cultures is 0%, and complete loss of cells
from the DP gate is 100%. The data from 11 experiments is shown
with mean response and standard deviation.
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ligands likely to induce positive versus negative se-
lection.
Identification of Self-Peptides Active
in the DP Dulling Assay
To identify naturally occurring self-peptide ligands, we
immunoprecipitated Kb molecules from LB27 tumor
cells. Associated peptides were eluted and fractionated
by reverse phase high pressure liquid chromatography
(HPLC). An aliquot of each HPLC fraction was tested in
OT-I cytolysis and DP dulling assays. No activity was
detected in any of these HPLC fractions in direct lysis
assays (data not shown). However, eight peaks of activ-
ity were seen using the DP dulling assay (Figure 3).
Kb-bound peptides purified from EL4 cells and screened
in the same manner gave a similar profile with seven
peaks present as opposed to eight (data not shown).
These peaks did not simply correspond to the most
abundant peptides, as judged by absorbance at 210 nm
(data not shown). Although theexact number of peptides
in these eight peaks that induce the dulling response
cannot be determined by this analysis, the data imply
that a relatively low number of different peptides have
the relevant properties to induce a thymocyte response.
Sequence Determination of a Self-Peptide
Active in the Dulling Assay
Prior to the experiments described above, we deter-
Figure 2. Comparison of the DP Dulling Assay with Mature CTL mined the sequences of three Kb-bound self-peptides
Response
via the method of membrane preconcentration-capillary
(A) The ability of an OT-I-derived CTL clone (CL.2) to recognize
electrophoresis-tandem mass spectrometry (mPC-CE-various Kb-binding peptides was tested in a 51Cr release assay using
MS/MS). This novel approach was specifically devel-the TAP-2-deficient target cell RMA-S as a target.
oped to separate and sequence low concentrations of(B) A DP dulling assay was performed with CD8tg, OT-I,b2Mo thymo-
cytes and TAPo APC in the presence of the same peptides. Percent structurally similar peptides (Tomlinson and Naylor,
dulling activity was calculated as in Figure 1B. The E1 and V-OVA 1995a, 1995b; Tomlinson et al., 1994). Current levels of
peptides were previously shown to induce positive selection, while sensitivity enable sequence determination of z10±50
the other three peptides are not recognized by OT-I cells (Hogquist
fmol of peptide. Peptides in a Kb immunoprecipitate fromet al., 1994).
3 3 109 EL4 cells were resolved by HPLC, and several
fractions were analyzed by mPC-CE-MS/MS. The se-
quences of three individual peptides were determined,at micromolar concentrations (Figure 2A), similar to pre-
vious reports (Hogquist et al., 1994). Strikingly, however, all of which precisely matched known mouse proteins
in the database (CPa1, NUbO, and PTP; listed in Tableboth E1 and V-OVA were potent in the DP dulling assay,
with titration into the nanomolar range (Figure 2B). The 1). All three peptides are octamers containing the pre-
dicted Kb ªanchor residuesº (Falk et al., 1991) and binddulling assay also detects the antigenic peptide ex-
tremely well, with sensitivity into the femtomolar range, Kb, as judged by the RMA-S stabilization assay (Table
1). These peptides derive from proteins of cytoplasmiccompared with titration at the low picomolar range for
the mature CTL (Figures 2A and 2B). Therefore, the DP localization, which is a feature common to peptides pre-
sented via the class I pathway. CPa1 and NUbO aredulling assay is a highly sensitive tool for detecting TCR
interactions, but it does not discriminate between those from ubiquitously expressed proteins, while PTP is from
Figure 3. Detection of Self-Peptides That
Promote DP Dulling
Fractions from an HPLC chromatographic
separationof peptides eluted from a Kb immu-
noprecipitate of 4 3 109 LB27 cells were
added to TAPo PEC. The dulling assay was
performed with CD8tg, OT-I,b2Mo thymo-
cytes. Percent dulling activity was calculated
as in Figure 1B, except that the dulling effect
seen incultures with 10 nMOVAp was consid-
ered 100%.
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Table 1. The Peptide Sequence, Protein Source, and Kb Binding of Seven Naturally Occurring Self-Peptides Compared with an Antigenic
Peptide OVAp
Peptide Half-Maximal
Sequence Name Protein Source [residue numbers] Binding to Kb
SIINFEKL OVAp Chicken ovalbumin [257±264] 6 nM
ISFKFDHL CPa1 F-actin capping protein subunit a1 [92±99] 22 nM
VNVDYSKL NUbO NADH ubiquinone oxidoreductase [61±68] 6 nM
AQYKFIYV PTP PTP-1c (SHP-1) phosphatase [503±510] 30 nM
HIYEFPQL P815p Unknown (expressed in P815 tumor cells) 3 nM
SNYLFTKL Lung Unknown (tissue-specific antigen) 7 nM
ASYEFTQL CDC Unknown (homology to yeast CDC protein) 6 nM
GAYEFTTL 40 kDa Unknown (homology to bacterial ribosomal 2 nM
protein)
CPa1, NUbO, and PTP are novel self-peptides presented by Kb, whose sequence was determined using mPC-CE-MS/MS and is reported
here. P815p and lung (Falk and Rotzschke, 1996) as well as CDC and 40 kDa (Hogquist et al., 1994) peptides have been previously described.
OVAp is the naturally processed and presented antigenic peptide for OT-I T cells. Putative Kb anchor residues are underlined. Since it was
not possible to distinguish Leu from Ile using the MAT 95Q hybrid mass spectrometer, we synthesized the four possible isomers of the CPa1
peptide and the two isomers of both the PTP and NUbO peptides. Of the four CPa1 isomers, ISFKFDHL bound Kb the best and is identical
to the murinecDNA±encoded amino acids (GenBankaccession number P47753). Both isomers of NUbO and PTP bound Kb; those corresponding
to the murine proteins (GenBank accession numbers U59509 and P29351) are listed.
a protein whose expression is limited to hematopoietic whether the CPa1 peptide, first, coeluted with one of
the peaks of DP dulling activity and, second, is normallycells.
These newly defined self-peptides, as well as four presented by Kb on living cells. To test this, we made a
CPa1/Kb-specific CTL line. Since we would predict B6other Kb-associated self-peptides that had previously
been reported (listed in Table 1), were synthesized and mice to be tolerant to this self-peptide, we generated
a peptide-specific allogeneic line. This was achievedtested in the DP dulling assay. The CPa1 peptide in-
duced a marked dulling response, titrating into the nano- through in vitro priming of H-2bm8 spleen cells with irradi-
ated H-2b TAPo cells in the presence of CPa1, essentiallymolar concentrations of peptide (Figure 4). All the other
self-peptides were negative in the dulling assay, even as described previously (Alexander-Miller et al., 1993).
This CTL line recognizes TAP-deficient targets coatedat high concentrations (Figure 4; data not shown). Ex-
cept for the Kb anchor residues (peptide residues 3, 5, with the CPa1 peptide, but not with any of ten other
Kb-binding peptides tested (Figure 5A; data not shown).and 8), none of these Kb self-peptides has sequence
homology to OVAp. Note, however, that the CPa1 pep- The CTL also lysed EL4 (Figure 5B) and LB27 targets
(data not shown), which confirms that these cell processtide has charge conservation with OVAp at positions 6
and 7 (Table 1): in OVAp these are TCR contact residues and present CPa1.
This CTL line is not very sensitive, requiring 16 nM(Jameson and Bevan, 1992; Fremont et al., 1995). The
significance of this similarity was explored in experi- CPa1 peptide for half-maximal killing. Nonetheless, CTL
were able to lyse targets coated with fraction 47, whichments described below.
was one of the ªminorº fractions for DP dulling activity
(Figure 5C). This suggests that the CPa1 peptide is aCPa1 Coelutes with a Kb-Associated Self-Peptide
Active in the DP Dulling Assay fairly abundant self-peptide. Note that five times the
volume of each fraction was used in the dulling assaySince the immunoprecipitate from which the peptide
sequences were determined was not the same as that compared with the CTL assay. Thus, the level of CTL
activity seen in fraction 47 is consistent with CPa1 beingused in Figure 3, we wished to investigate further
the active peptide for that fraction in the DP dulling
assay, although it is certainly possible that more than
one bioactive peptide elutes in fraction 47. We are cur-
rently attempting to define the sequences of the two
major peaks of dulling activity in fractions 56 and 59.
CPa1 Peptide Induces Positive Selection
of OT-I Thymocytes
Based on the correlation between the activity of syn-
thetic peptides in the dulling assay and in FTOC (Figure
2), we predicted that the CPa1 peptide might induce
positive selection of CD81 T cells in organ cultures of
OT-I,TAPo mice. Figure 6Ashows that CPa1 does indeedFigure 4. The CPa1 Peptide Has Activity in the Dulling Assay
induce a profound skewing of organ culture thymocytes
The DP dulling assay was performed with CD8tg, OT-I,b2Mo thymo-
to the CD81 subset. A 7-fold increase in the number ofcytes and TAPo PEC in the presence of various concentrations of
mature CD81 cells was seen compared with the controlthe peptides listed. Percent dulling activity was calculated as in
Figure 3. cultures (see yield of CD8SP in Figure 6A). An unrelated
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Figure 5. Characterization of a CPa1-Specific CTL Line
(A) CPa1/Kb-specific CTL were generated as described in Experimental Procedures and tested in a 51Cr release assay against RMA-S plus
the indicated peptides. An E:T ratio of 3:1 was used.
(B) The same CTL were tested for lysis of EL4, RMA-S, or RMA-S pulsed with 10 mM CPa1 peptide, at various E:T ratios as shown.
(C) Lysis by CPa1-specific CTL coelutes with a minor peak of activity in the dulling asssay. Fractions from the HPLC chromatographic
separation of self-peptides described in Figure 3 were tested for activity in a 51Cr release assay, using RMA-S as the target and CPa1-specific
CTL as effectors. The percent specific lysis in each fraction is shown overlaid on the DP dulling activity of the same fractions. In a repeat of
this CTL assay using the same effectors, fraction 47 was positive, but fractions 83±87 were not (data not shown).
self-peptide, P815p, had no effect on OT-I selection, FTOCs with CPa1 compared with those from control or
P815p cultures, indicating that CD81 cells selected bydespite the fact that, at 500 mM, P815p caused consider-
ably better stabilization of Kb in these cultures than did CPa1 are functionally competent.
CPa1 (see Kb stabilization in Figure 6A). This confirms
earlier work suggesting that specific peptides, rather Contact Residues in CPa1 Required
for Bioactivitythan overall Kb levels, dictate positive selection. A similar
increase in positive selection of CD81 thymocytes was As pointed out previously, CPa1 has similarity to OVAp
at the carboxyl terminus, including a potential chargealso seen using 20 mM CPa1 (data not shown).
CPa1 induced development of CD81 T cells that were conservation of the TCR contact positions 6 and 7. This
charge conservation is of interest since it has been sug-phenotypically mature (Figure 6A; data not shown), but
we wished to determine whether they were functionally gested that these amino acids in OVAp may contact
residues in the CDR3 regions of both the TCRa and bresponsive. Thymocytes from the experiment in Figure
6A were tested for their ability to proliferate to EL4 cells chains of OVAp/Kb-specific CTL (Kelly et al., 1993). In
contrast, the amino-terminal residues are quite differentwithout or with the selecting peptide or OVAp (Figure
6B). None of the thymocytes responded to APC alone between the two peptides. To test the significance of
this for the bioactivity of CPa1, we made single or multi-or to the ªselectingº peptide, but they were able to re-
spond to OVAp-pulsed EL4 (Figure 6B). We observed a ple amino acid substitutions of this peptide. An alanine
ªscanº of each position of the peptide was screened,small degree of leakiness in TAPo FTOC with respect to
CD8 development (compared with our previous experi- as well as a panel of variants which carried OVAp resi-
dues at certain TCR contact sites (Table 2). These pep-ence with b2Mo FTOC; see Figure 6B, none), and this is
reflected in the capacity of thymocytes from unmanipu- tides were initially screened for their capacity to bind
Kb in an RMA-S stabilization assay. As expected fromlated OT-I TAPo organ cultures to respond to OVAp.
However, the magnitude of the anti-OVAp/EL4 prolifera- previous work (Jameson and Bevan, 1992; Shibata et
al., 1992), alanine substitutions at positions 3, 5, and 8tive response was clearly greater in thymocytes from
Immunity
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Figure 6. The CPa1 Peptide Induces Positive
Selection of OT-I Thymocytes
(A) FTOC was performed using OT-I,TAPo thy-
mic lobes in media with or without the indi-
cated peptide at 500 mM. The CD8 versus
CD4 staining profile of total thymocytes is
shown. Kb stabilization was determined by
staining with antibodies to Kb (Y3), CD4, and
CD8. The data shown are the mean fluores-
cence intensity of the Y3 staining after gating
on CD41CD82 cells. (A similar relationship
was seen without gating, or after gating on
double negative cells.) The yield of CD8 single
positive cells (3104) per lobe is shown. These
data are representative of four experiments.
(B) Thymocytes selected on CPa1 are func-
tionally responsive to OVAp. Thymocytes
from the organ cultures described in Figure
8 were assayed for their proliferative re-
sponse to irradiated EL4 cells, in the pres-
ence of 500 nM OVAp, 500 mM of the appro-
priate selecting peptide (P815p or CPa1), or
no peptide. [3H]thymidine incorporation was
determined after 48 hr.
reduced Kb binding. Surprisingly, an alanine substitution CPE6K7 mutant, which is 50% identical to the OVAp
peptide. We also observed that the slightly decreasedat position 1 also decreased Kb binding. The other sub-
stitutions had little effect on Kb binding (Table 2). The activity of CPK7 compared with CPa1 was compensated
by Asp→Glu substitution at position 6, suggesting thatanalogous peptide from residues 94±101 of the closely
related a2 subunit (CPa2) was also studied. CPa1 and these two side chains may cooperate in TCR en-
gagement.CPa2 peptides differ only at position 2 (Ser→Cys), yet
this change dramatically impairs the ability of CPa2 to Overall, these data indicate that the residues at posi-
tions 2, 4, and 7 of CPa1, but not position 6, contributebind Kb. With such low affinity, it is questionable whether
CPa2 would be presented by Kb in vivo (Schafer et al., directly to TCR recognition in the dulling assay. The
flexibility of position 6 is intriguing, since it implies that1996).
Those peptides that had a reasonable ability to bind the relevant homology between CPa1 and OVAp is even
lower than expected from examination of the se-Kb (,100 nM for half-maximal Kb stabilization) were fur-
ther tested for activity in the DP dulling assay (Figure quences: from this analysis, only one OT-I TCR contact
residue in CPa1 (His-7) is even similar to the analogous7). The most dramatic affect on dulling activity was seen
when the histidine at position 7 was changed to alanine position in OVAp (Lys). These data highlight the pitfalls
of searching for bioactive self-peptides on the basis of(CPA7), decreasing activity by .100-fold. Conservative
substitutions with lysine or arginine at position 7 (CPK7 homology with the antigenic ligand and suggest that,
as has been seen in other systems, a single TCR canand CPR7) were more potent in the dulling assay, but
still not as active as wild-type CPa1. In marked contrast, interact with quite different MHC±peptide ligands (Tall-
quist et al., 1996; Wucherpfennig and Strominger, 1995;none of the position 6 variants of CPa1 (CPA6 and CPE6)
had an effect. The only other differences that could not Evavold et al., 1995; Nanda et al., 1995).
be accounted for by decreased Kb binding were due to
alanine replacement at positions 2 and 4. These results Expression of Capping Protein a1 in Mouse
Thymic Epitheliumare similar to those seen with mutations of OVAp. Thus,
position 4 of OVAp is typically an important TCR contact Taken together, our data show that an octamer peptide
from the a1 subunit of F-actin capping protein can beresidue (Chen et al., 1993; Jameson et al., 1993) and
although position 2 of OVAp is buried in the Kb groove processed and presented by Kb and induce positive
selection of OT-I thymocytes. This protein is ubiqui-(Fremont et al., 1995), it has been previously reported
that alteration of this residue can dramatically affect T tously expressed in mice (Hart et al., submitted), sug-
gesting that the CPa1 peptide could play a role in posi-cell recognition (Chen et al., 1993). Interestingly, none
of the variants had greater activity than CPa1, even the tive selection in vivo. To confirm that this protein is
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Table 2. The Name, Sequence, and Kb Binding Capacity of 13 Variants of CPa1
Peptide Name Peptide Sequence Peptide Concentration Required for
Half-Maximal Kb Binding (nM)
OVAp SIINFEKL 6
CPa1 ISFKFDHL 22
CPA1 ASFKFDHL 700
CPA2 IAFKFDHL 13
CPA3 ISAKFDHL 800
CPA4 ISFAFDHL 2
CPA5 ISFKADHL 2500
CPA6 ISFKFAHL 65
CPA7 ISFKFDAL 65
CPA8 ISFKFDHA 2500
CPE6 ISFKFEHL 6
CPK7 ISFKFDKL 6
CPR7 ISFKFDRL 6
CPE6K7 ISFKFEKL 6
CPa2 ICFKFDHL 650
Residues that are different from the parent CPa1 peptide are shown in bold. Also listed are the properties of CPa2 (residues 94±101) of the
mouse F-actin capping protein a2 subunit, Kb binding was determined using the RMA-S stabilization assay. The average of two experiments
is shown.
expressed in thymic epithelial cells, we analyzed the development of the CD81 T cell repertoire. Analysis in-
volving TCR transgenic animals permitted design ofexpression of both the a and b subunits by Western blot
in the thymic epithelial cell line 427.1 (Figure 8). This peptides that mediate positive or negative selection and
has lead to determination of the TCR affinity for thesecell line has previously been shown to induce positive
selection after intrathymic injection in vivo (Vukmanovic different ligands. Nonetheless, some controversy sur-
rounds the role that specific peptides play in positiveet al., 1992). The 427.1 line expresses both a1 and a2
subunits, as shown, as well as the b1 subunit. Data from selection in vivo (Schumacher and Ploegh, 1994). This
highlights the point that our understanding of positivea similar analysis of normal thymic stroma (a heteroge-
neous population generated using deoxy-guanosine- selection in vivo demands identification of the actual
self-peptide ligands that direct it, i.e., the self-peptidestreated fetal thymic lobes) revealed that these cells also
express the a1 subunit (data not shown). These data that interact with the TCR in the thymus.
Using the modified DP dulling assay, we were able tosuggest that the CPa1 peptide could be presented by
MHC molecules on the relevant thymic cells to mediate identify eight fractions of activity that coprecipitate with
the Kb molecule. This suggests that at least eight differ-positive selection events.
ent Kb-bound self-peptides are capable of interacting
with the OT-I receptor. This number could be an under-Discussion
estimate for two reasons: multiple bioactive peptides
may coelute in the same HPLC fractions, and we mayThe nature of the TCR interaction that mediates positive
selection and how it is distinguished from negative se- be missing peptides owing to their low abundance in
the immunoprecipitates or their weaker engagement oflection is poorly understood. One factor that has be-
come prominent in recent years is the role of MHC- OT-I thymocytes (or both). Since activity in this assay
is a characteristic of all synthetic positive selecting pep-associated peptides. Using knockout mice defective in
class I MHC presentation, it has been possible to deter- tides tested, this small pool of self-peptides are strong
candidates for natural positive selecting peptides. Thismine the effect of single or multiple peptides on the
Figure 7. DP Dulling Activity of Variants of the CPa1 Peptide
The CPa1 variants are listed in Table 2. The DP dulling assay was performed using thymocytes from CD8tg, OT-I,b2Mo mice and TAPo APC.
The calculation of percent activity was the same as that described in Figure 4.
Immunity
396
Our data perhaps fit best with the ªgemischº model
of positive selection, which proposed that multiple self-
peptides can select a single TCR (Bevan et al., 1994).
Each selecting peptide may be of low abundance or
bind the TCR with low affinity (or both), but together
they may cooperate to reach a suitable threshold for
thymocyte selection. Alternatively, the eight self-pep-
Figure 8. The a1 Subunit of F-Actin Capping Protein Is Expressed
tides could work independently, each having the capac-in Thymic Epithelial Cells
ity to select the TCR alone. At present we cannot distin-427.1 cells (1 3 106) were lysed in IEF buffer and resolved by two-
guish between these possibilities, but it is of interest thatdimensional immunoblotting. The blot was probed for the a and b
theone self-peptide identified, CPa1,has the capacity tosubunits of F-actin capping protein. The differences in molecular
mass and pI of mouse a1 (32.7 kDa, 5.3), a2 (32.9 kDa, 5.7), b1 (30.6 drive positive selection of OT-I thymocytes on its own
kDa, 5.5), and b2 (31.4 kDa, 5.8) polypeptides were the basis for (albeit at a high concentration). If CPa1 is sufficient but
their identification. not necessary for positive selection of the OT-I receptor,
then its elimination (e.g., by a directed knockout of the
correlation was strengthened by the identificationof one CPa1 epitope) would not be expected to influence OT-I
of the bioactive self-peptides, identified as CPa1, which positive selection significantly. On the other hand, if
is capable of inducing positive selection of OT-I in thy- CPa1 and the other natural positive selecting peptides
mic organ culture. are each present at a critical density, they may operate
Of course, the self-peptides studied here were iso- in concert for selection of thymocytes with the OT-I TCR.
lated from lymphoid tumor cells because of the large cell Thus, elimination of any one of the selecting peptides
numbers required. The self-peptides involved in positive could beenough to block or at least reduce OT-I positive
selection in vivo are those expressed on thymic epithe- selection. Further experiments will be required to dis-
lial cells. Thus, our approach may have missed relevant criminate between these models. It will also be of inter-
self-peptides if they were not expressed on tumor cells. est to determine whether OVAp/Kb-specific TCRs that
While such tissue-specific peptides would certainly be utilize distinct V regions can recognize these same eight
expected to exist, they were not so numerous as to peptides, an overlapping set, or have a completely dif-
be detected in a previous study (Marrack et al., 1993). ferent ªselfº specificity.
Furthermore, we present data that at least one of the The CPa1 peptide is derived from a ubiquitously ex-
peptides identified from tumor cells (CPa1) is also pres- pressed protein involved in cytoskeletal remodeling. We
ent in thymic epithelium. showed that this peptide is found in association with Kb
If this assay recapitulates the specificity of positive at relatively high abundance and that the protein can
selection, it would imply that positive selection in vivo be detected in thymic epithelial cells. Together, these
is not so extremely specific that only one or two self-
data indicate that CPa1 has both the capacity and the
peptides can drive the process. Nor is positive selection
opportunity to drive positive selection of cells bearing
so flexible that any MHC-binding peptide can contribute.
the OT-I receptor. However, direct evidence that it does
This latter point may seem at odds with the recently
so in vivo requires further experimentation. Interestingly,
published phenotype of mice expressing homogenous
this peptide is neither an agonist nor an antagonist for
MHC±peptide complexes, either as a result of expres-
the OT-I receptor in conventional assays (data not
sion of an engineered MHC±peptide molecule (Ignatow-
shown). This may seem to be in contrast with what hasicz et al., 1996), loss of the DM protein (Miyazaki et al.,
been published with synthetic peptides, where agonists1996; Fung-Leung et al., 1996; Martin et al., 1996), or
(Ashton-Rickardt et al., 1994; Sebzda et al., 1994) andexpression of ªemptyº MHC class I molecules (van San-
antagonists (Hogquist, et al., 1994) were found to induceten et al., 1995). In these animals, significant numbers
positive selection. One possibility is that the TCR inter-of peripheral CD4s or CD8s were seen, despite their
action with this ligand is even ªweakerº than that withsevere reduction in peptide complexity associated with
an antagonist or weakagonist. This fitswith ourobserva-MHC molecules. This was interpreted to mean that pep-
tion that CPa1 needs to be present at a considerablytide complexity is not important for positively selecting
higher concentration than potent TCR antagonists toa diverse TCR repertoire. However, both positive and
induce positive selection. Based on the known OT-I af-negative selection were impacted in these mice, and
finities for agonists and antagonists (Alam et al., 1996),the contribution of each could not be separated. In an
we might predict that CPa1/Kb will bind OT-I with a veryexperimental situation where negative selection was left
low affinity; this is currently being evaluated.unaffected, while positive selection was limited to only
These data demonstrate that the self-reactivity of athe single MHC±peptide complexes (a wild-type into
single T cell is limited to a set of self-peptides. As such,mutant bone marrow chimera), the defect in peripheral
the knowledge of the sequence of one of these peptidesT cell numbers was much greater (C. Surh, personal
provides the opportunity to address biological issuescommunication). Thus, it seems that peptide diversity is
related to self-reactivity of T cells, in addition to thatcritical for positive selection in the presence of ongoing
of positive selection. For example, it is possible thatnegative selection to a wide variety of self-peptides.
animals undergoing a response to ovalbumin can cross-Additionally, analysis of TCR transgenics, such as
react on cells that express high levels of CPa1, tempo-shown here, offers a glimpse of the selection require-
rarily resulting in autoimmunity. A potential role of self-ments in a normal animal, since the genes were cloned
peptides in maintenance of CTL memory may also befrom a mouse whose T cells underwent selection in
response to the natural set of thymic self peptides. interesting to explore.
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Experimental Procedures 378C, cells were washed and stained for Kb expression using bio-
tin±Y3 and streptavidin±PE.
Fetal thymic organ culture (FTOC) was performed essentially asCells and Cell Lines
The H-2b thymoma EL4 was grown in tissue culture (RPMI, 5% FCS, described (Hogquist et al., 1994), except that OT-I,TAPo animals
were used as opposed to OT-I,b2Mo animals, and exogenous humanplus antibiotics, 2-ME, and L-glutamine) or as an ascites in C57BL/6
mice. The H-2bxd B cell tumor LB27.4 was grown in tissue culture in b2M was not added. After 7 days, thymocytes were stained for
expression of Va2 (the OT-I transgenic TCR a chain), CD4 and CD8,the same media. The thymic epithelial cell line 427.1 was grown in
media with 10% FCS. CTL clones and lines were stimulated on a or were tested for their capacity to respond to antigen in a 2 day
proliferation assay determined by [3H]thymidine incorporation, asweekly basis with appropriate APC and IL-2, essentially as de-
scribed (Jameson and Bevan, 1992). Deoxy-guanosine-treated thy- described previously.
The OT-I-derived CTL clone, CL.2, has been described (Jamesonmic epithelial cells were prepared from gd16 thymi, cultured in the
presence of 3.5 mM deoxyguanosine (Sigma, St. Louis, MO). Cells et al., 1994). CPa1-specific CTL were generated through in vitro
priming of bm8 spleen cells with irradiated TAPo spleen cells inwere recovered 5 days later, and a single cell suspension was gener-
ated. Less than 5% Thy-11 cells were observed in this preparation, the presence of 500 nM CPa1 peptide essentially as described
(Alexander-Miller et al., 1993). All of the cells in this line expressedand the majority of the cells were MHC class II1 (data not shown).
CD8 but not CD4 after the second round of stimulation. CTL function
was determined in a 51Cr release assay as described (Jameson andMice
Bevan, 1992), using 3 3 104 CTL and 104 51Cr-labeled target cells inOT-I is a C57BL/6 TCR tg strain, expressing a receptor specific for
a 4 hr assay, unless otherwise indicated.OVAp/Kb (Hogquist et al., 1994). CD8tg is a C57BL/6 strain overex-
pressing CD8b and CD8a under the control of the CD2 promoter
Western Blot Analysis of Capping Proteins(Robey et al., 1991). TAPo is a 129 3 C57BL/6 strain with a targeted
Approximately 106 thymic epithelial cells (427.1 cell line or heteroge-disruption of the TAP-1 gene on both chromosomes (gift of Anton
neous normal thymic stromal cells) were solubilized in 100 ml ofBerns, Netherlands Cancer Institute). b2Mo is a 129 3 C57BL/6 strain
isoelectric focusing (IEF) sample buffer (13 M urea, 4% NP-40, 50with a targeted disruption of b2-microglobulin (b2M) on both chro-
mM DTT, 3.2% ampholines [pH 5±8], 0.8% ampholines [pH 3±10]).mosomes (Koller et al., 1990).
We analyzed 5 ml of sample by two-dimensional immunoblotting as
previously described (Schafer et al., 1994). The blots were probedPeptide Synthesis
with the monoclonal antibody, MAb 5B12, which recognizes the a1Peptides were synthesized by standard Fmoc chemistry at the Uni-
and a2 subunits (Schafer et al., 1996) and a pan-reactive anti-CPbversity of Minnesota Biomedical Engineering Division or by Re-
polyclonal antibody, R22 (Hart et al., submitted), followed by alkalinesearch Genetics (Huntsville, AL). Typically, peptides were purified
phosphatase±conjugated secondary antibodies (Tago Immunologi-by reverse phase HPLC and analyzed by TOF mass spectrometry.
cals, Camarillo, CA). The differences in molecular mass and pI ofThe variants of CPa1 peptide were used without HPLC purification,
mouse a1 (32.7 kDa, 5.3), a2 (32.9 kDa, 5.7), b1 (30.6 kDa, 5.5), andbut purity was determined by mass spectrometry before use.
b2 (31.4 kDa, 5.8) polypeptides were the basis for their identification.
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